Skip to content
Search

Latest Stories

Taxi and ambulance drivers 'less likely to die' from Alzheimer's

Working in these professions may have a protective effect against Alzheimer's disease

Taxi and ambulance drivers 'less likely to die' from Alzheimer's

Taxi and ambulance drivers had the lowest proportion of deaths due to Alzheimer's disease.

Getty Images/iStockphoto

DEATHS due to Alzheimer's disease were found to be lowest among taxi and ambulance drivers, who frequently process spatial and navigational information, according to a new study.

The findings, published in the British Medical Journal, suggest that working in these professions may have a protective effect against Alzheimer's disease, an age-related condition that progressively deteriorates memory, thinking, and daily functioning.


Researchers, including those from Massachusetts General Hospital, analysed death data from the US National Vital Statistics System for adults across 443 different occupations.

Of the nearly nine million people whose occupational information was available, almost four percent had Alzheimer's disease listed as a cause of death, the researchers found.

Among the 16,658 taxi drivers, about one percent (171) died from Alzheimer's disease, while 10 of 1,348 ambulance drivers (0.74 per cent) died from the neurodegenerative condition.

Compared to the general population and all other occupations examined, taxi and ambulance drivers had the lowest proportion of deaths due to Alzheimer's disease.

This trend was not observed in other transport-related jobs, such as bus drivers or aircraft pilots, possibly due to their reliance on pre-determined routes, the authors noted.

They also pointed out that the trend was not seen in individuals suffering from other forms of dementia, suggesting that neurological changes in the brain's hippocampus region -- or elsewhere -- among taxi and ambulance drivers may explain the reduced Alzheimer's risk.

The hippocampus, a brain region involved in memory, learning, and decision-making, plays a critical role in spatial memory and navigation. This area is also known to be affected in Alzheimer's disease.

The authors referenced a previous study showing that London taxi drivers had an enhanced hippocampus compared to the general population.

However, as this was an observational study, the researchers cautioned that no cause-and-effect conclusions could be drawn.

"In an analysis of nearly all death certificates in the United States, taxi drivers and ambulance drivers, whose jobs require frequent spatial and navigational processing, were found to be the occupations with the two lowest risk-adjusted percentages of deaths due to Alzheimer's disease," the authors wrote.

"Further research is necessary to definitively determine whether the spatial cognitive work required in these occupations affects the risk of death from Alzheimer's disease, and whether any cognitive activities can potentially be preventive," they wrote.

(PTI)

More For You

Serena Williams

Williams explained that her weight challenges began after the birth of her first daughter

Getty Images

Serena Williams says GLP-1 made her feel light physically and mentally after 31lb loss

Highlights:

  • Serena Williams reveals she has lost more than 31lbs using a GLP-1 medication
  • The tennis legend says the treatment enhanced her existing healthy lifestyle
  • She stresses that weight loss should not change self-image or self-confidence

Serena Williams has revealed she has lost more than 31lbs after turning to a weight-loss medication, saying the treatment has transformed both her body and her mindset.

The 23-time Grand Slam champion, 43, told PEOPLE that using a GLP-1 medication — a type of injection that works by regulating appetite — has helped enhance the healthy lifestyle she already maintained through diet and exercise.

Keep ReadingShow less
Monica Seles

Seles first began noticing symptoms around five years ago

Getty Images

Tennis champion Monica Seles reveals living with myasthenia gravis

Highlights:

  • Nine-time Grand Slam winner Monica Seles diagnosed with myasthenia gravis three years ago
  • The 51-year-old revealed her condition ahead of this month’s US Open to raise awareness
  • Disease causes muscle weakness and has no known cure

Former world number one Monica Seles has revealed she was diagnosed with myasthenia gravis, a rare neuromuscular autoimmune disease, three years ago. The 51-year-old, who won nine Grand Slam singles titles, went public ahead of the US Open to raise awareness of the condition, which causes muscle weakness and can affect multiple parts of the body.

Symptoms and diagnosis

Seles first began noticing symptoms around five years ago when she experienced double vision and struggled with coordination. “I would be playing [tennis] with some kids or family members, and I would miss a ball. I was like, ‘Yeah, I see two balls,’” she told the Associated Press. These symptoms eventually led to her diagnosis, which took time for her to come to terms with.

Keep ReadingShow less
faulty knee implant NHS recall

Hundreds of patients required corrective surgery

iStock

Faulty knee implant recalled after being used in over 10,000 NHS surgeries

Highlights:

  • NexGen knee implant linked to high failure rates was used in over 10,000 UK operations.
  • Concerns flagged as early as 2014; withdrawn from UK market in 2022.
  • Hundreds of patients required corrective surgery, with costs running into millions.
  • Manufacturer Zimmer Biomet says patient safety is its “top priority” but will not cover revision costs up front.

Implant used despite early warnings

A knee replacement implant used in thousands of NHS operations was known to have a concerning failure rate eight years before it was withdrawn, a BBC File on 4 Investigates report has found.

The NexGen implant, made by US manufacturer Zimmer Biomet, was fitted in more than 10,000 patients between 2012 and 2022. Concerns were first raised by the National Joint Registry (NJR) in 2014, though insufficient data at the time made it difficult to draw firm conclusions.

Keep ReadingShow less
health

A 34-year-old woman developed 43 aggressive skin cancer lesions triggered by HPV

iStock

Oral sex linked to skin cancer risk through stealth HPV infections, scientists warn

Highlights:

  • HPV, a common STI, is now potentially linked to a deadly form of skin cancer
  • A 34-year-old woman developed 43 aggressive skin cancer lesions triggered by HPV
  • Researchers say this discovery could shift the approach to diagnosing and treating some skin cancers
  • Protection measures include vaccination, safe sex practices, and regular screening


Human papillomavirus (HPV), one of the most widespread sexually transmitted infections in the UK, is already associated with several serious cancers — cervical, throat, penile, anal, and head and neck cancers among them. Now, researchers in the US have raised concerns that it may also contribute to certain forms of skin cancer, especially in people with weakened immune systems.

Scientists from the National Institutes of Health (NIH) found signs of beta-HPV triggering squamous cell carcinoma in a young woman who had no major history of sun damage or other typical causes.

Keep ReadingShow less
CardioPrecision

The approach aims to reduce pain, shorten hospital stays, and improve patient outcomes

MediaZoo

CardioPrecision performs world-first robot-assisted aortic valve replacement via neck incision

Highlights:

  • Glasgow-based CardioPrecision completes first clinical cases of robotic aortic valve replacement (AVR) through a small neck incision.
  • The procedure was carried out at Cleveland Clinic in the United States.
  • It uses the company’s CoreVista® Robot Enabling Platform to perform minimally invasive surgery.
  • The approach aims to reduce pain, shorten hospital stays, and improve patient outcomes.
  • Early results presented at major international conferences show clinical promise.


Glasgow medtech firm CardioPrecision has successfully performed the world’s first clinical cases of robot-assisted aortic valve replacement (AVR) using a small transcervical incision. This breakthrough could significantly reduce the need for traditional open-heart surgery.

The pioneering operations were carried out at the Cleveland Clinic in the United States, a centre globally recognised for its cardiovascular care. The procedures used CardioPrecision’s proprietary CoreVista® Robot Enabling Platform, offering a new route for accessing the heart valve via the neck rather than the chest.

Keep ReadingShow less